Main menu
Click categories to expand
A-Z listingplugin-autotooltip__plain plugin-autotooltip_bigA-Z listing
This is an alphabetical index of all content pages.
Other categories
Utilities
Also see
Importance Ratings
News
Legal
Donate/Sponsor
Curator's rationale
AI Policy
Twitter feed ð•
Feeds + s.e.o. etc.
rss / xml feed 
sitemap file
A-Z listing (archived)
Bimatoprost is a drug used to treat Glaucomaplugin-autotooltip__plain plugin-autotooltip_bigGlaucoma
Glaucoma is a group of eye diseases - the leading cause of non-reversible blindness worldwide. It's linked* with increased intra-ocular pressure (IOP) and results in damage to the retinal cells and the optic nerve. (Note the increased IOP is also sometimes cal… - linked to excess pressure within the eye. It currently has more than 2 million prescriptions per year in the US alone. Marketed, usually as eye-drops, under the brand names Lumigan, Latisse, Vistitan and others.
Its mechanism of action is unknown. No prostamide receptor has yet been identified. See : Wikipedia
Note: Its also used to treat excess eyelash growth - also with an unknown mechanism of action.
Also see : Betaxololplugin-autotooltip__plain plugin-autotooltip_bigBetaxolol
Betaxolol - currently sold under brand names Betoptic, Betoptic S, Lokren, Kerlone and others - is a prescription drug used to treat Glaucomaand its associated ocular hypertension. It was patented in 1975 and was first licenced for medical use over forty year…
Ideas for new topics, and suggested additions / corrections for older ones, are always welcome.
If you have skills or interests in a particular field, and have suggestions for Wikenigma, get in touch !
Or, if you'd like to become a regular contributor . . . request a login password. Registered users can edit the entire content of the site, and also create new pages.
( The 'Notes for contributors' section in the main menu has further information and guidelines etc.)
You are currently viewing an auto-translated version of Wikenigma
Please be aware that no automatic translation engines are 100% accurate, and so the auto-translated content will very probably feature errors and omissions.
Nevertheless, Wikenigma hopes that the translated content will help to attract a wider global audience.
DOKUWIKI IMPLEMENTATION DESIGN BY UNIV.ORG.UK DECEMBER 2023